Micro biome biomarkers are emerging as valuable tools for assessing gut health and identifying disease risk. These biological indicators help researchers and clinicians understand microbial composition, function, and its relationship with human health and disease.
Advancements in sequencing technologies and bioinformatics have enabled more precise and comprehensive micro biome analysis. These tools are being used to detect early signs of diseases, monitor treatment responses, and support personalized healthcare strategies.
This session will focus on the development and application of micro biome-based diagnostics, highlighting their potential in clinical practice, research, and preventive medicine.